icatibant (firazyr) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$622.9303

VA FSS

$971.5233 - $7466.8267

VA Big4

$3793.3700 - $3793.9700

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
icatibant acetate 10 mg / 1 mL (1 mL INJECTION) $971.5233 VA FSS
  • Icatibant (3)
    		•  Fresenius Kabi, LLC
    icatibant acetate 10 mg / 1 mL (1 mL INJECTION) $1207.4600 VA FSS
  • Icatibant (3)
    		•  AvKare, LLC
    icatibant acetate 10 mg / 1 mL (1 mL INJECTION) $2914.5733 VA FSS
  • Icatibant (3)
    		•  Fresenius Kabi, LLC
    icatibant acetate 10 mg / 1 mL (1 mL INJECTION) $3622.3833 VA FSS
  • Icatibant (3)
    		•  AvKare, LLC
    icatibant acetate 30 mg / 3 mL (3 mL INJECTION) $622.9303 AUS PBS generic
  • Cipla Icatibant (1)
    		•  Cipla Australia Pty Ltd
    icatibant acetate 30 mg / 3 mL (3 mL INJECTION) $3793.3700 VA Big4
  • Firazyr (1)
    		•  Takeda Pharmaceuticals America, Inc.
    icatibant acetate 30 mg / 3 mL (3 mL INJECTION) $3793.9700 VA Big4
  • Firazyr (3)
    		•  Takeda Pharmaceuticals America, Inc.
    icatibant acetate 30 mg / 3 mL (3 mL INJECTION) $7466.8200 VA FSS
  • Firazyr (1)
    		•  Takeda Pharmaceuticals America, Inc.
    icatibant acetate 30 mg / 3 mL (3 mL INJECTION) $7466.8267 VA FSS
  • Firazyr (3)
    		•  Takeda Pharmaceuticals America, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue